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ABSTRACT 
Much of the literature on heroin and opioid addiction holds that regular, long-term users of heroin and other opioids 
lose interest in sex as their drug using careers lengthen. Analysis of self-reports collected from IDUs in two cross-
sectional surveys on patterns of risk behavior in Miami-Dade County, Florida, reveals that large proportions of IDUs 
report using heroin before or during sex across a wide range of self-injection experience, from as little as twelve 
months to over 40 years.  One half or more of respondents to both surveys reported using heroin in their recent sexual 
experiences, with similar proportions reported by both males and females. The same IDUs, however, tend not to report 
using prescription painkillers before or during sex. This finding indicates that co-occurring risk behavior related to 
both sexual behavior and heroin use may be more prevalent among long-term IDUs than previous literature has 
suggested.  
Florida Public Health Review, 2016; 13, 73-81. 
BACKGROUND 
Various studies have examined the relationship 
between drug use and sexual behavior (Benotsch et 
al., 2011; Johnson et al., 2013; Rawson et al., 2002; 
Ross & Williams, 2001), and their primary 
conclusion has been that opioids, both illicit ones 
such as heroin and prescription ones such as 
OxyContin, have a dampening effect on sexual desire 
or appetite. Some reports (e.g., Ross & Williams, 
2001) attribute sexual stimulation to use of 
stimulants, such as methamphetamine or cocaine, but 
those that report primarily on the use of heroin and 
prescription opioids in connection with sexual 
behavior (Rhodes et al., 1998; Rigg & Murphy, 2013; 
Young et al., 2012) conclude that use of opioids 
results in loss of libido and impaired sexual 
performance.  
The literature on whether or not use of opioids 
enhances the sexual experience of opioid users is 
sparse, and much of what has been written focuses on 
how the drugs affect the sex drive and performance 
of long-term users. The existing literature also 
depends heavily on retrospective commentary by 
heroin users elicited while in treatment for addiction 
(Bang-Ping 2009; De Leon & Wexler 1973; La Pera 
et al., 2003; Palha & Esteves, 2002; Palha & Esteves 
2008; Rawson et al., 2002). With the exception of 
their sexual experience during incipient heroin use 
(Palha & Esteves, 2008), consumers of heroin in 
most of these studies reported effects on sexual 
function that were consistently negative.  
Nevertheless, the notion that opioid drugs have quasi-
orgasmic effects, and that sexual pleasure can be 
enhanced by use of opioids in conjunction with 
sexual activity is actually old (Pfaus & Gorzalka 
1987), dating back to the 1560s and the writings of 
Garcia D’Orta (Guerra, 1974). Physicians and early 
writers often likened the effects of opioids to sexual 
orgasm (John Jones quoted in Pfaus & Gorzalka 
1987).   
These accounts make it clear that for a long time 
physicians and other people who commented on the 
effects of laudanum, morphine, and eventually heroin 
made a connection between the experience of sexual 
orgasm and the acute effects of large doses of opioid 
preparations. Pfaus and Gorzalka (1987), in their 
comprehensive review paper on this topic, distinguish 
between the effects of acute intoxication by opioids 
and the effects of long-term, regular use of these 
drugs. The sexual enhancement effects of opioids 
occurred in the reviewed studies primarily in opioid 
naïve or novice experimenters with this class of drug 
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(Palha & Esteves, 2002; Palha & Esteves 2008).  At 
an early stage in the careers of some opioid users, this 
class of drug had apparently been attractive to 
prospective users as an enhancer of sex. The studies 
conducted by Palha and Esteves (2002; 2008) 
revealed that up to one-third of the respondents had 
been attracted to heroin use in part as a sexually 
enhancing drug. La Pera et al. (2003) found that one-
fifth of the respondents in their study of heroin users 
had reported sexual dysfunction before beginning to 
take heroin. These findings suggest that some 
younger heroin users might have become involved in 
taking heroin for the purpose of dealing with sexual 
dysfunction. A subset of both male and female heroin 
users in the study conducted by Palha and Esteves 
(2008) persisted in using heroin as an enhancer of 
sexual pleasure. The nature of this enhancement 
involved a combination of arousal, disinhibition, 
removal of insecurity, and delay of ejaculation.  
These findings raise questions with regard to the 
variation in how heroin users incorporate heroin use 
into their sexual lives and at what point the heroin 
makes them no longer interested in sex at all.  In 
addition, it could be useful to pose these questions to 
a database elicited from active heroin users rather 
than recovering treatment patients. 
 
Purpose 
In a behavioral surveillance study of people at risk 
for exposure to HIV, respondents have reported that 
they used heroin during sexual experiences in the 
previous 12 months. The present paper uses the 
behavioral surveillance data from two rounds of the 
National HIV Behavioral Surveillance (NHBS) 
carried out in Miami-Dade County, Florida, to 
characterize this response to heroin use during sex in 
terms of socio-demographics and user lifestyles. 
 
METHODS 
Data presented in this paper was collected in 
Miami-Dade County, Florida, as part of the Centers 
for Disease Control and Prevention-funded National 
HIV Behavioral Surveillance system (NHBS). NHBS 
is conducted among three target populations at 
increased risk of HIV infection: men who have sex 
with men (MSM), injection drug users (IDU), and 
heterosexuals at increased risk of HIV infection 
(HET).These three target populations are 
systematically sampled in recurring cycles, with each 
target population resampled every three years, 
referred to as a “round.” The interviews are 
anonymous so there is no record of who is sampled 
from one year to the next, thus, this is not a 
longitudinal repeated survey of the same respondents 
over time. Rather, it is three cross-sectional surveys 
of IDUs (IDU1, IDU2, and IDU3). This paper 
analyzes data collected during two rounds of NHBS 
among Injection Drug Users: NHBS-IDU2 in 2009 
and NHBS-IDU3 in 2012. For each round, 
respondent-driven sampling (RDS), was used to 
recruit over 500 study respondents each study round. 
In each survey, trained interviewers conducted face-
to-face interviews, using a multisite protocol created 
by the CDC. All data were collected anonymously, 
focusing on sexual risk, alcohol and drug use 
behaviors and HIV testing and treatment. Rapid HIV 
testing was conducted after the interviews using a 
blood sample collected via finger stick for both 
NHBS-IDU2 and NHBS-IDU3. For those who were 
reactive or self-reported HIV-positive status, a 
confirmatory Western blot test was conducted. 
Eligible respondents for all NHBS-IDU cycles were 
residents of Miami-Dade County, Florida, were male 
or female (not transgender), reported injection drug 
use during the 12-month period prior to the date of 
the interview, were at least 18 years of age, and 
provided informed consent. Respondents for all 
cycles received $25 for their time to complete the 
interview and $25 for their time to complete the HIV 
test. Respondents eligible to recruit others for the 
survey received $10 for each eligible recruit that 
completed the survey up to $50 total for five 
referrals, in keeping with Heckathorn’s (Heckathorn, 
Broadhead & Sergeyev, 2001; Heckathorn, 2002) 
principles of respondent-driven sampling (RDS). A 
detailed description of the NHBS-IDU study 
methodology has been reported elsewhere (Lansky et 
al., 2007). 
  In response to the survey, respondents reported 
their age the first time they injected drugs. This age 
could be subtracted from their age at the date of the 
interview to obtain an estimate in years of the 
duration of the drug using career of each respondent.  
This measure was then categorized into deciles of 
less than 12 months to 40 or more years. The surveys 
also included questions about the different drugs used 
before or during the last sexual encounter within the 
past 12 months as well as the date of last sex with 
male and female sex partners. For both rounds the 
following questions were asked: “Before or during 
the last time you had sex with this partner, did you 
use alcohol, drugs, both alcohol and drugs, or neither 
one?” Respondents who reported using drugs before 
or during last sex within the past 12 months were 
then asked a multiple choice question to identify 
which drugs were used before or during the 
respondent’s last sexual encounter. The possible 
drugs included: marijuana, speedball (heroin and 
cocaine used together), heroin, crack cocaine, powder 
cocaine, crystal methamphetamine, X or ecstasy, 
special K or ketamine, GHB, pain killers 
(OxyContin, Vicodin, Percocet), downers (Valium, 
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Ativan, Xanax), and other drugs. Respondents were 
asked these questions separately for last sexual 
encounter with a male partner with the past 12 
months and last sexual encounter with a female 
partner within the past 12 months. The characteristics 
of all IDU for NHBS-IDU2 and NHBS-IDU3 and of 
those who reported heroin before or during last sex 
within the past 12 months are presented in Table 1. 
The proportions of respondents who reported using 
heroin before or during last sex within the past 12 
months were obtained for NHBS-IDU2, NHBS-IDU3 
and NHBS-IDU2 & NHBS-IDU3 combined and are 
presented in Table 2. The proportions of respondents 
who reported using prescription pain killers before or 
during last sex within the past 12 months were 
obtained for cross-sectional surveys NHBS-IDU2, 
NHBS-IDU3 and NHBS-IDU2 and NHBS-IDU3 
combined and are presented in Table 3. 
We first give, in Table 1, percentages of different 
demographic characteristics within all IDU in the 
whole sample and then the proportion within those 
who used heroin before or during last sex in the past 
12 months for both the NHBS-IDU2 and NHBS-
IDU3 rounds. In Table 2, we examined proportions 
of those using heroin with sex within the 
respondent’s gender and the respondent’s partner’s 
gender, specific to the years of IDU exposure. This 
was done for males reporting sex with females, males 
reporting sex with males, females reporting sex with 
males and overall for both NBHS-IDU2 and NHBS-
IDU3 rounds combined. We used a chi-square 
analysis of proportions to determine if exposure time 
was related to the proportion of IDU users who 
reported using heroin before or during their last 
sexual encounter in the past 12 months, more or less 
or equally, across the exposure time.  For the males, 
for example, did those groups that had different 
length of exposure to heroin have differences in the 
proportion of those using heroin with sex.  The chi-
square test of linear relationship (either increasing or 
decreasing) in the proportion was used, which would 
detect if there was a cumulative effect of increasing 
time of exposure on proportions using heroin with 
sex, which, if you followed the assumption of the 
previous reports, would show as a decreasing 
downward gradient of the proportions in the table 
(i.e., less IDUs would use during sexual encounters 
the longer they used). These tests were also 
conducted for the use of prescription opioids during 
last sex in the past 12 months (Table 3). 
 Although all respondents in this paper reported sex 
with heroin within the past 12 months, we also 
analyzed time since last sex for any patterns. We 
present the means and standard deviations of time 
since last sex with heroin overall and within one of 
the decile groups of duration of injection that was 
significant.  
All analyses are based on un-weighted data and a 
p-value less than or equal to .05 was considered 




The sample characteristics were similar across both 
rounds of NHBS-IDU (Table 1).  Both samples were 
mostly distributed across the 30-39 (IDU2 19%; 
IDU3 24.9%), 40-49 (IDU2 30.8%; IDU3 27.4%) 
and 50+ (IDU2 42.2%; IDU3 32.2%) age groups, 
with smaller numbers among the 18-22 (IDU2 0.8%; 
IDU3 3.1%) and 23-29 (IDU2 7.3%; IDU3 12.5%) 
age groups. The IDU2 sample was 19.7 percent white 
(males 16.9%, females 28.7%), 39.7 percent Black 
(males 39.8%, females 39.2%),  38.9 percent 
Hispanic (males 42%, females 28.7%) and  1.8 
percent other (males 1.3%, females 3.5%). The IDU3 
sample was 28.2 percent white (males 22.3%, 
females 44.3%), 26.2 percent Black (males 27.8%, 
females 22.1%), 44.6 percent Hispanic (males 49.2%, 
females 32.1%) and 1 percent other (males 0.8%, 
females 1.4%). 
Most respondents were born in the US (IDU2 
males 69%, females 90.9%; IDU3 males 71.9%, 
females 86.4%). Many respondents reported being 
homeless during the past 12 months (IDU2 males 
19.1%, females 21.7%; IDU3 males 21.7%, females 
25%) or currently homeless (IDU2 males 50.3%, 
females 41.3%; IDU3 males 46.1%, females 40.7%). 
Level of education was similar for men and women 
and across both rounds of IDU with 35.6% of IDU2 
and 36.2% of IDU3 reporting less than 12 grade 
education, 39.2% of IDU2 and 36.2% of IDU3 
reporting completing high school or GED, and 
approximately 22.7% of IDU2 and 23.6 of IDU3 
reporting completing some college, an associate’s 
degree, or technical training. Annual income was also 
similar for both male and female respondents across 
both rounds of IDU with 85.3% of IDU2 and 80.5% 
of IDU3 reporting annual incomes between $0 and 
$19,000 and 9.6% of IDU2 and 13.4% of IDU3 
reporting annual incomes between $20,000 and 
$39,000. 
Table 2 displays the relationship of time since IDU 
exposure and the proportion using heroin before or 
during sex in their last sexual encounter in the past 12 
months. In general, over half of all heroin users 
report using heroin before or during their last sexual 
encounter within the past 12 months, with 60.8 
percent of all IDUs for IDU2, 57.6 percent of all 
IDUs for IDU3, and 59.3 percent of all IDUs for both 
rounds combined (Table 2). The use of prescription 
pain killers before or during last sex, as reported in 
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IDU2 and IDU3, was much lower at less than three 
percent of all IDUs for each cycle (Table 3). In 
general, there are fewer females than males in our 
sample, which is seen in other studies (Palha & 
Esteves, 2002). Nevertheless, the percentages of 
respondents using heroin in conjunction with sex are 
similar between males having sex with females and 
females having sex with males. Only males having 
sex with males in IDU2 and IDU2 and IDU3 
combined showed any differences that were 
statistically significant (Table 2). The data presented 
in Table 2 clearly indicate that heroin use in 
conjunction with sexual behavior remains high 
throughout the duration of IDU heroin use careers 
and much later than hypothesized.  Contrary to the 
hypothesis that more of the less experienced opioid 
users, and less of the more experienced users, would 
report having sex under the influence of opiates, the 
results indicate that in most cases there are no 
significant differences in the proportion of those who 
use heroin in conjunction with sex across the range of 
IDU exposure time, and when there are significant 
differences over time, and the patterns fluctuate with 
no consistency and clearly no significant linear trend 
to decline over time (Table 2).  Both males users 
having sex with females and females users having 
sex with males reported the same proportion of 
combining last sexual encounter and heroin within 
the past 12 months whether their exposure to heroin 
was short or very long. Considerably larger 
proportions of respondents reported heroin as an 
accompaniment for sexual activity than did users of 
prescription opioids, with less than three percent of 
all IDUs in IDU2 and IDU3 reporting prescription 
opioid use with their last sexual encounter (Table 3). 
We performed a simple logistic regression including 
only gender and time since first use of heroin. The 
model showed that there were neither gender 
differences (IDU2, χ2(1)=0.52, p=.473, IDU3, 
χ2(1)=1.73, p=.189) nor IDU exposure time 
differences (IDU2, χ2(4)=5.48, p=.241, IDU3, 
χ2(4)=5.20, p=.267)  in the proportion of respondents 
who reported heroin use with their last sexual 
encounter within the past 12 months. The only 
significant gender by heroin exposure time 
interaction occurred in IDU3 (χ2(4)=11.66, p= .020), 
wherein male respondents showed significantly lower 
rates of opioid use with last sexual encounter than did 
female respondents between 6 and 20 years of their 
injection drug using career (Men vs. Women: 6-10 
years of use, OR=.30, 95% CI[0.09, 0.99]; 11-20 
years OR=0.39 95% CI[0.17, 0.921]). This clearly 
does not indicate large gender difference associations 
or time to exposure associations with the proportions 
of respondents using heroin with sex in the past 12 
months. Note that due to the small numbers who 
reported the use of prescription opioids with last sex 
in the past 12 months in IDU2 and IDU3, the logistic 
models were not estimated. 
We also examined whether the length of time since 
their last sexual encounter with heroin exhibited any 
patterns across the different deciles of duration of 
injection exposure. In the two rounds of IDU 
surveillance in Miami reported here, most 
respondents who used heroin in conjunction with sex 
reported sexual activity relatively recently, regardless 
of the duration of their drug using careers (data not 
shown in table). The overall average of time since 
last sex with heroin for both NHBS-IDU2 
(Mean=0.99, SD=1.15) and NHBS-IDU3 
(Mean=1.27, SD=1.78) is less than one and a half 
months.  Only one decile group in NHBS-IDU3 (i.e., 
those reporting duration of injection of 31 to 35 
years) has an average time since last sex with heroin 
of greater than one and a half months (Mean=2.39, 
SD=3.14). This indicates that, in all except one decile 
group, there were no differences in the length of time 
since last sex with heroin in the male sex with female 
category, male sex with male category, female sex 
with male category, all heroin with last sex category, 
and in both rounds (i.e., the same categories shown in 
Table 2). 
Several study limitations should be recognized.  
These data are from a sample of IDUs recruited by 
respondent-driven sampling in Miami-Dade County, 
Florida, and are not necessarily representative of 
IDUs in this county or other areas.  These data are 
self-reported and, as such, stigmatized behaviors may 
have been underreported.  Finally, these data are 
repeated cross-sectional surveys, so we did not 
directly observe change in sexual behavior as 
duration of drug use increased, but rather compared 
reports of individuals with differing duration of drug 
use at the time of the sampling, although other 
studies have found consistent use over time. 
 
DISCUSSION 
Given the tenor of the background literature on this 
topic, which held that heroin users tended to lose 
interest in sex once they became regular in their 
heroin use, including loss of interest in sex over time 
(Palha & Esteves, 2008) and decreasing desire for sex 
with increasing age (Bang-Ping, 2009), we were 
surprised to find the extensive association between 
heroin consumption and sexual activity among 
survey respondents. The majority of heroin users, 
both male and female, and novice and experienced, 
reported, not only that they used heroin in 
conjunction with sexual activity in the past 12 
months, but they continued to do so years after the 
start of IDU.  Even long-term heroin users, using for 
20 or more years, continued to consume heroin in 
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conjunction with sexual activity.  Although some 
literature has shown opioid users to still be sexually 
active at older ages, up to 34, (Palha & Esteves, 
2002), we found significant numbers of users across a 
longer span of drug use and here provide a more 
refined breakdown by length of time of exposure to 
opioids and a further refinement by respondent’s 
gender and partner’s gender than other literature on 
this topic. We also found, that mostly, there was not a 
large difference in the amount of time since using 
drugs with sex across gender and rounds, which 
could also be some indication that their self-reported 
drug effects on their sexual desires were not affecting 
their behavior of using drugs with sex.  
In the previous literature on sexual activity and 
heroin use (Bang-Ping 2009; De Leon & Wexler, 
1973; La Pera et al., 2003; Palha & Esteves, 2002; 
Palha & Esteves, 2008), the research depended 
heavily on retrospective narratives elicited from 
addicts in treatment. The principal difference 
between those studies and the data presented here lies 
in the recruitment of active drug users.  Perhaps the 
respondents in the studies mentioned above had only 
experienced the full ravages of addiction. This 
experience is the most extreme variant of heroin use, 
but it is not the only form of use found among active 
users. Given the self-reported frequency of heroin use 
among the respondents in the two rounds of NHBS-
IDU studied here, ranging from more than once a day 
to once a month or less, many respondents would fall 
outside of the addicted pace of heroin consumption. 
Their reduced frequency of use may account for the 
persistence of sexual activity while using heroin, 
even among long-term users, but we saw no strong 
evidence that frequency of use went down the longer 
the exposure (data not shown), which has been seen 
in other studies (Shah et al., 2006). Although the 
project that gathered the data presented here also 
collected some qualitative, open-ended interviews, 
these were too limited to help explain the survey 
findings about heroin and sex.  Still, our data 
showing such high rates of heroin use in conjunction 
with sex may explain the high rates of unprotected 
sex reported in the literature.  Further probing of 
these behavior patterns will be necessary to achieve a 
full understanding of how sexual behavior is linked 
to heroin use.   
As stated in the methods section, we obtained an 
estimate of the number of years in the drug using 
career of each respondent by subtracting their 
reported age the first time they injected drugs from 
their age at the date of the interview.  While the 
survey did not collect data on possible periods of 
cessation of drug use during this drug using career, 
literature suggests that the majority of injectors who 
cease injection subsequently resume injection within 
a short period (Evans et al., 2009; Shah et al., 2006)  
In a long term study of cessation among injection 
drug users in Baltimore conducted between 1988 and 
2000, three-fourths of those who ceased injecting 
subsequently resumed injection drug use, with half of 
these resuming within one year (Shah et al.,2006). 
Similarly, in a San Francisco study conducted 
between 2000 and 2008, of the 29% of young IDU 
who reported ceasing injection for three or more 
months, two-thirds relapsed to injection (Evans et al., 
2009).  
Despite the possibility of prescription opiates’ 
meeting the other needs of heroin users (e.g. opioid 
pleasure and avoidance of withdrawal), the data show 
clearly that the same group of users did not associate 
these drugs with sex to near the extent they did with 
heroin.  Most survey respondents did not self-report 
use of prescription opioids, and of those who did, half 
or fewer connected that use with sexual activity.  
Apparently, the widespread misuse of prescription 
pain medications in the U.S. had little effect on the 
connection made by respondents between heroin and 
sex, despite their affinity for opiates and other drugs. 
  
Implications for Public Health Practice 
The fact that heroin has a consistent connection 
with sexual behavior among the respondents in the 
two IDU surveys presented here is of concern, 
because that connection facilitates a nexus between 
two forms of potential health risk: unprotected sex 
and needle/syringe use in intimate circumstances.  
Have long term users devised a way to cope with the 
difficulties that heroin introduces into their sex lives 
in order to stay sexually active? Could those methods 
be modified to include safe sex practices?  We 
recommend that future inquiries into drug using 
behavior include sufficient depth of qualitative study 
to understand the nature of risk in these surprisingly 
frequent behaviors in long term users to determine 
the social norms that pair sex and drugs together, in 
both males and females. 
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